Bay Street News, February, 2019

EVANSTON, Ill., Feb. 14, 2019 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that […]

Recognizes New Logistics Visibility Product Suite for Innovation and Industry Impact WOODCLIFF LAKE, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) — […]

CLEVELAND, Feb. 14, 2019 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2018 financial results at approximately […]

MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that it […]

SM-88 therapy did not exhibit typical side effects associated with hormonal castration from androgen-deprivation therapy (ADT) 87% of patients (20/23) […]

Achieved Record Revenue in 2018 Continued Strength in Investment Banking and Brokerage NEW YORK, Feb. 14, 2019 (GLOBE NEWSWIRE) — […]

CRANBURY, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported financial results and business […]

REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage […]

BRISBANE, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development […]

Premier Industry Journal to Highlight Corporate Growth and Rebranding TAMPA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc. […]